Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Harvard Bioscience Inc (NASDAQ: HBIO) was $0.99 for the day, down -16.10% from the previous closing price of $1.18. In other words, the price has decreased by -$16.10 from its previous closing price. On the day, 0.9 million shares were traded.
Ratios:
Our analysis of HBIO’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 2.06. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, The Benchmark Company on March 10, 2023, Upgraded its rating to Buy and sets its target price to $4 from $3 previously.
On December 09, 2020, Northland Capital started tracking the stock assigning a Outperform rating and target price of $6.Northland Capital initiated its Outperform rating on December 09, 2020, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 13 ’24 when Green James W bought 10,000 shares for $2.91 per share. The transaction valued at 29,100 led to the insider holds 3,111,091 shares of the business.
Green James W bought 20,000 shares of HBIO for $61,400 on Jun 06 ’24. The Chief Executive Officer now owns 3,101,091 shares after completing the transaction at $3.07 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 0.66.
Stock Price History:
Over the past 52 weeks, HBIO has reached a high of $4.70, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -46.35%, while the 200-Day Moving Average is calculated to be -61.43%.
Shares Statistics:
A total of 43.62M shares are outstanding, with a floating share count of 37.64M. Insiders hold about 13.71% of the company’s shares, while institutions hold 70.43% stake in the company.
